ClinicalTrials.govrestricted
16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis
ClinicalTrials.gov study NCT02159053. IPD Sharing: UNDECIDED. Countries: 19. Publications: 6.
ShareScore
40/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 16
- Harmonization
- 12
- Access
- 4
- Reuse readiness
- 0
- Engagement
- 8